Crinetics Pharmaceuticals GAAP EPS of -$1.14 beats by $0.07, revenue of $25.12M beats by $10.25M (CRNX:NASDAQ)
· seekingalpha.com
Crinetics (CRNX) Q2 earnings: GAAP EPS beat and revenue surged on PALSONIFY sales; plus Vertex’s $10B acquisition deal.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...